Patterns of comorbidities, clinical course, and impact of the ABC Pathway for Integrated Care in patients with atrial fibrillation: a report from the prospective Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) Registry.

IF 4.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Marta Mantovani, Tommaso Bucci, Jacopo F Imberti, Steven H M Lam, Agnieszka Kotalczyk, Giuseppe Boriani, Yutao Guo, Gregory Y H Lip
{"title":"Patterns of comorbidities, clinical course, and impact of the ABC Pathway for Integrated Care in patients with atrial fibrillation: a report from the prospective Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) Registry.","authors":"Marta Mantovani, Tommaso Bucci, Jacopo F Imberti, Steven H M Lam, Agnieszka Kotalczyk, Giuseppe Boriani, Yutao Guo, Gregory Y H Lip","doi":"10.1093/ehjqcco/qcaf014","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To identify comorbidities patterns in elderly Chinese patients with atrial fibrillation (AF), their clinical course, and the effectiveness of the Atrial fibrillation Better Care (ABC) pathway adherence among these phenotypes.</p><p><strong>Methods: </strong>From the ChiOTEAF Registry, we performed a latent class analysis based on 16 cardiovascular (CV) and non-CV conditions. The association between classes of patients, management, and outcomes was evaluated. The primary outcome was a composite of all-cause death and major adverse cardiovascular events. We assessed the impact of ABC adherence on outcomes in the whole cohort and among phenotypes.</p><p><strong>Results: </strong>We included 4765 AF patients (median age 77 [68-83] years, 39.1% females). Four phenotypes were identified: (1) Low complexity (48.9%); (2) Atherosclerotic (19.3%); (3) Heart failure (19.4%); and (4) High complexity (12.3%).During a 1-year follow-up, compared to the 'low complexity' class, the risk of adverse events was higher in 'high complexity' (aOR, 95% CI: 3.20, 2.21-4.66) and 'heart failure' classes (aOR, 95% CI: 1.50, 1.04-2.17).Among 2654 patients (median age 75 [66-81] years, 43.3% females) with available information to assess the ABC pathway, 1094 (41.2%) were adherent. ABC pathway adherence was associated with a lower risk (aOR, 95% CI: 0.37, 0.20-0.65). On interaction analysis, its beneficial effect was similar across different clinical phenotypes (Pint = 0.122).</p><p><strong>Conclusion: </strong>Different clinical phenotypes can be identified in Asian AF patients, with specific patterns of comorbidities and different risks of adverse events. Full ABC pathway adherence was associated with improved outcomes, regardless of the clinical phenotype.</p>","PeriodicalId":11869,"journal":{"name":"European Heart Journal - Quality of Care and Clinical Outcomes","volume":" ","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal - Quality of Care and Clinical Outcomes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ehjqcco/qcaf014","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: To identify comorbidities patterns in elderly Chinese patients with atrial fibrillation (AF), their clinical course, and the effectiveness of the Atrial fibrillation Better Care (ABC) pathway adherence among these phenotypes.

Methods: From the ChiOTEAF Registry, we performed a latent class analysis based on 16 cardiovascular (CV) and non-CV conditions. The association between classes of patients, management, and outcomes was evaluated. The primary outcome was a composite of all-cause death and major adverse cardiovascular events. We assessed the impact of ABC adherence on outcomes in the whole cohort and among phenotypes.

Results: We included 4765 AF patients (median age 77 [68-83] years, 39.1% females). Four phenotypes were identified: (1) Low complexity (48.9%); (2) Atherosclerotic (19.3%); (3) Heart failure (19.4%); and (4) High complexity (12.3%).During a 1-year follow-up, compared to the 'low complexity' class, the risk of adverse events was higher in 'high complexity' (aOR, 95% CI: 3.20, 2.21-4.66) and 'heart failure' classes (aOR, 95% CI: 1.50, 1.04-2.17).Among 2654 patients (median age 75 [66-81] years, 43.3% females) with available information to assess the ABC pathway, 1094 (41.2%) were adherent. ABC pathway adherence was associated with a lower risk (aOR, 95% CI: 0.37, 0.20-0.65). On interaction analysis, its beneficial effect was similar across different clinical phenotypes (Pint = 0.122).

Conclusion: Different clinical phenotypes can be identified in Asian AF patients, with specific patterns of comorbidities and different risks of adverse events. Full ABC pathway adherence was associated with improved outcomes, regardless of the clinical phenotype.

房颤患者ABC途径综合护理的合并症模式、临床病程和影响:来自中国老年房颤患者前瞻性最佳血栓预防(ChiOTEAF)登记的报告。
目的:确定中国老年房颤(AF)患者的合并症模式,其临床病程,以及房颤更好护理(ABC)途径依从性在这些表型中的有效性。方法:从ChiOTEAF注册表中,我们基于16种心血管(CV)和非CV疾病进行了潜在分类分析。评估了患者类别、管理和结果之间的关系。主要结局是全因死亡和主要不良心血管事件的综合结果。我们评估了ABC依从性对整个队列和各表型结果的影响。结果:我们纳入4765例房颤患者(中位年龄77[68-83]岁,女性39.1%)。4种表型:(1)低复杂性(48.9%);②动脉粥样硬化(19.3%);(3)心力衰竭(19.4%);(4)复杂性高(12.3%)。在1年的随访中,与“低复杂性”组相比,“高复杂性”组(aOR, 95% CI: 3.20, 2.21-4.66)和“心力衰竭”组(aOR, 95% CI: 1.50, 1.04-2.17)的不良事件风险更高。2654例患者(中位年龄75岁[66-81]岁,43.3%女性)具有评估ABC通路的可用信息,其中1094例(41.2%)患者是依从性的。ABC途径依从性与较低的风险相关(aOR, 95% CI: 0.37, 0.20-0.65)。在相互作用分析中,不同临床表型的有益效果相似(Pint = 0.122)。结论:亚洲房颤患者具有不同的临床表型,具有特定的合并症模式和不同的不良事件风险。无论临床表型如何,完全ABC通路的依从性与改善的结果相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
9.40
自引率
3.80%
发文量
76
期刊介绍: European Heart Journal - Quality of Care & Clinical Outcomes is an English language, peer-reviewed journal dedicated to publishing cardiovascular outcomes research. It serves as an official journal of the European Society of Cardiology and maintains a close alliance with the European Heart Health Institute. The journal disseminates original research and topical reviews contributed by health scientists globally, with a focus on the quality of care and its impact on cardiovascular outcomes at the hospital, national, and international levels. It provides a platform for presenting the most outstanding cardiovascular outcomes research to influence cardiovascular public health policy on a global scale. Additionally, the journal aims to motivate young investigators and foster the growth of the outcomes research community.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信